A nalogous to the endothelial cell control of leukocyte extravasation from the bloodstream into surrounding tissue, mesothelial cells, which line the peritoneal cavity, gate leukocyte trafficking into this body cavity (1) . Consistent with this role, human peritoneal mesothelial cells (HPMC) 3 constitutively express intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1, and platelet-endothelial cell adhesion molecule-1 (2-5). ICAM-1 and vascular cell adhesion molecule-1 expression are up-regulated after inflammation in vivo or cytokine stimulation in vitro and appear to play a functional role in leukocyte adherence to and migration across the mesothelium (3, 4, 6) . Chemokine secretion by cytokine-activated HPMC also plays a central role in the process of leukocyte recruitment, and the creation of a chemotactic gradient across the mesothelium appears to be the primary determinant to the degree and direction of cell trafficking (7) .
To date, cytokine-activated HPMC have been shown to secrete both neutrophil-specific CXC (IL-8 and growth-related oncogene (GRO) ␣) and mononuclear-specific CC chemokines (monocyte chemoattractant protein (MCP)-1, RANTES and inflammatory protein-10; Ref. 8) . Studies that use a transwell culture systems, in which polarized cultures of HPMC are established on porous inserts, have demonstrated that chemokine secretion by IL-1␤-or TNF-␣-activated HPMC is directional, with Ͼ80% of the chemokine secreted apically, resulting in the formation of a chemotactic gradient across the cell monolayer. Furthermore, specific Ab blocking studies have demonstrated a direct role for HPMC-derived IL-8 and MCP-1 in mediating increased transmesothelial polymorphonuclear leukocyte (PMN) and MNC migration, respectively (7) . Evidence for similar mechanisms occurring in vivo arises from studies showing elevation of i.p. levels of these same chemokines during peritoneal inflammation, which correlated directly with the number and phenotype of the recruited cell populations (9 -12) .
Although recent studies have established an important role for HPMC-derived chemokine and adhesion molecule expression in mediating PMN and MNC influx into the peritoneal cavity, little is known about the mechanisms that control the switch in the phenotype of cell infiltrate from PMN to MNC (13) . Measurement of i.p. cytokine levels during peritoneal dialysis-associated peritonitis suggests that i.p. elevation of the T cell-derived cytokines IFN-␥, IL-2, and IL-10 occur during infection (14, 15) . Recent in vitro studies indicate that IFN-␥ is capable of modulating both CXC and CC chemokine secretion in a number of cell types, data that suggest that it plays a central role in controlling leukocyte influx (16 -18) . However, the role of IFN-␥ in the control of peritoneal leukocyte recruitment has not been determined.
In the present study, we have examined the effects of IFN-␥ on neutrophil and mononuclear-specific chemokine production by cytokine (IL-1␤ or TNF-␣)-activated HPMC, and investigated the potential of IFN-␥ to modulate the transmesothelial migration of PMN both in vitro and in vivo. Our results indicate that IFN-␥ has differential effects on MCP-1, RANTES, and IL-8 production. These changes in chemokine secretion correlated directly with the ability of IFN-␥ to down-regulate IL-1␤-or TNF-␣-induced PMN transmesothelial migration both in vitro and in vivo. The ability of IFN-␥ to differentially modulate chemokine production and ultimately transmesothelial leukocyte migration may be a further mechanism by which IFN-␥ promotes mononuclear phagocyte function and the development of Th1-type responses.
Materials and Methods
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich (Poole, Dorset, U.K.). Recombinant human IL-1␤, TNF-␣, and IFN-␥ were obtained from R&D Systems (Abingdon, U.K.). The specific activity of IFN-␥ was 10 7 U/mg protein. Recombinant murine IL-1␤ and IFN-␥ were obtained from PeproTech EC, (London, U.K.). Endotoxin levels in recombinant cytokines were less than 0.1 ng/g (1 EU/g) protein.
Culture inserts and 24-well companion plates, tissue culture flasks, and all multiwell plates were obtained from Falcon (BD Biosciences, Oxford, U.K.). Digoxigenin (DIG)-labeled mixtures of oligonucleotide probes to MCP-1, RANTES, IL-8, and ␤-actin were obtained from R&D Systems. All reagents used for the detection of DIG-labeled probes were from Boehringer Mannheim (Lewes, U.K.).
Isolation and culture of HPMC
HPMC obtained from the omental tissue of consenting patients undergoing abdominal surgery, were isolated and characterized as described previously (19) . Cells were maintained in Earle's buffered M199 culture medium (Sigma) supplemented with penicillin (100 U/ml), streptomycin (100 g/ml), and L-glutamine (2 mM; all obtained from Life Technologies, Paisley, U.K.), transferrin (5 g/ml), insulin (5 g/ml), hydrocortisone (0.4 g/ml; Sigma) and 10% (v/v) FCS (Perbioscience, Tattenhall, U.K.). Cultures were passaged with trypsin-EDTA-glucose (0.125% (w/v), 0.01% (w/v), 0.1% (w/v)) and maintained at 37°C in a humidified 5% CO 2 atmosphere.
All data presented are from experiments performed with confluent HPMC from the second passage. All cells were washed and growth arrested for 48 h in serum-free, hydrocortisone-free culture medium before cytokine stimulation.
Establishment of a HPMC monolayer on the underside of porous culture inserts
Tissue culture inserts containing a 3-m porous polycarbonate membrane (diameter, 6.25 mm; pore density, 1.6 ϫ 10 6 /cm 2 ; BD Biosciences) were coated with human type IV collagen (Sigma) by the addition of 100 l of collagen solution (100 g/ml collagen in 0.1% (v/v) acetic acid) to the upper surface of the inverted insert for 1 h at room temperature. Excess collagen was washed off with PBS before the addition of 150 l of neutralized rat tail collagen I solution (6 mg/ml in 0.1% (v/v) acetic acid) to the inner chamber of the insert placed upright in a 24-well insert culture plate (BD Biosciences). Inserts were incubated at 37°C for 30 min to allow the collagen I plugs to set. HPMC (3 ϫ 10 5 cells/insert) in serum-free culture medium then were added to the upper (collagen IV-coated) surface of the inverted insert and incubated for 4 h at 37°C to allow cell attachment. Inserts were placed upright in 24-well plates containing 1 ml of medium supplemented with 5% (v/v) FCS, and 0.4 ml of serum-free medium was added to the inner chamber of the insert. HPMC were cultured on the underside of the inserts to allow leukocyte migration across the mesothelial monolayer in a physiological direction. The absence of FCS in the medium added to the upper chamber and the presence of a collagen I plug was necessary to maintain a monolayer of mesothelial cells on the underside of the membrane (7). Cells were grown for 5-7 days and the medium was replaced every day. The confluence and integrity of the mesothelial monolayer was routinely monitored by light microscopy and by measuring transmesothelial electrical resistance (Millipore ERS resistance meter; Millipore, Bedford, U.K.), which was corrected for the control resistance across an identical collagen I and IV-coated, cell-free insert. Transmesothelial electrical resistance increased from 10 Ϯ 5 ohms/insert (mean Ϯ SEM, n ϭ 3) on days 1-45 Ϯ 5 ohms/insert (mean Ϯ SEM, n ϭ 3) by days 5-7 of culture, and remained at 43 Ϯ 3 ohms/insert (mean Ϯ SEM, n ϭ 3) after a 48-h growth-arrest period in serum-free medium. Monolayer integrity also was assessed by fixing the inserts in 2.5% glutaraldehyde for 1 h at room temperature before sectioning for light microscopy.
Leukocyte isolation
PMN preparations were freshly isolated from venous blood taken from healthy human volunteers. Citrated blood was dextran-sedimented and leukocytes separated by Ficoll-Hypaque (Pharmacia Biotech, Uppsala, Sweden) gradient centrifugation. PMN preparations were routinely Ͼ99% pure, as determined by morphological assessment of Neat-stained (Guest Medical, Sevenoaks, U.K.) cytospin preparations.
Transmigration experiments
Collagen type I plugs were removed from growth-arrested HPMC insert cultures before apical stimulation with 1 ml of fresh serum-free medium, in the presence or absence of cytokines. Fresh serum-free medium (0.4 ml) was added to the upper chamber. After a 24-hour stimulation period, 240 l of supernatant in the upper chamber was replaced with 240 l of fresh serum-free medium. This adjustment was performed to correct for the different medium volumes present on either side of the HPMC monolayer, thus allowing any secreted (in apical vs basal direction) chemokine gradient to form. PMN (2 ϫ 10 6 ) in 30 l of M199 were added to the upper chamber and the inserts incubated at 37°C. After a 1-h incubation period, the inserts were removed and the number of transmigrated PMN in the lower well quantitated with a myeloperoxidase assay as described previously (3).
Chemokine synthesis measurements
Growth-arrested HPMC in 48-well culture plates were stimulated at 37°C with 0.5 ml of fresh serum-free medium in the presence or absence of IL-1␤, TNF-␣, or IFN-␥, alone or in combination, for the times and doses specified in Results. HPMC supernatants were harvested, centrifuged to remove cellular debris, and stored at Ϫ80°C until assayed by ELISA. Cell monolayers were carefully washed twice with PBS and solubilized with 0.1 M NaOH. Total cellular protein was analyzed by the modified Bradford method with BSA as the standard (20) . Repeated cell counts revealed that 1 g of cellular protein was equivalent to 3400 Ϯ 900 cells (n ϭ 5). All data for chemokine production are expressed as pg/g of cell protein.
Chemokine levels in cell supernatants were quantitated with specific sandwich ELISA. MCP-1 assays were performed as previously described (21), and IL-8 and RANTES ELISA were established with Ab pairs from R&D systems, according to the manufacturers instructions. Intraperitoneal murine KC levels were analyzed in lavage fluid with the Quantakine M mouse KC ELISA (MKC00; R&D Systems) as per the manufacturer's instructions.
RNA extraction and isolation
Total cellular RNA was extracted from control or cytokine-stimulated HPMC cultured in six-well plates by lysis with 1 ml of RNA isolator (Genosys Biotechnologies, Cambridge, U.K.). RNA was separated from DNA and proteins by the addition of chloroform and precipitated with isopropanol, essentially as described in the manufacturer's instructions (Genosys Biotechnologies). RNA was quantitated by measuring OD 260 before reverse transcription and PCR amplification or Northern blot analysis.
Reverse transcription and PCR amplification
Total cellular RNA was reversed-transcribed into cDNA with M-MLV Superscript reverse transcriptase (Life Technologies) by the random hexamers method, as described previously (22) . To ensure exponential phase amplification, PCR was performed with 25 cycles for ␤-actin, 25 cycles for MCP-1, 33 cycles for RANTES, and 30 cycles for IL-8. One-tenth of the PCR product was separated by flat-bed electrophoresis in 3% (w/v) NuSieve GTG agarose gels (Flowgen Instruments, Sittingbourne, U.K.), stained with ethidium bromide (1 g/ml), and photographed. The negatives were analyzed by densitometry (Model GS670 video densitometer; BioRad Laboratories, Hemel Hempstead, U.K.) and the density of the chemokine bands compared with those of the housekeeping gene.
Northern blot analysis
Total cellular RNA (10 g) was fractionated on a formaldehyde, 1% agarose gel. RNA was transferred overnight to a positively charged nylon membrane (Boehringer Mannheim) by capillary action and fixed by UV irradiation. Membranes were hybridized and DIG-labeled probes detected, as described previously (27) . Visualization was achieved by using the chemiluminescent substrate CSPD (Boehringer Mannheim). Blots were exposed to x-ray film for ϳ1-2 h at room temperature. Membranes were stripped by incubating twice for 30 min each in boiling 0.1% (w/v) SDS in RNase-free water, rehybridized with fresh DIG-labeled oligonucleotide probe, and developed as described above. Autoradiographs were quantitated by densitometry and expressed as a ratio of the house-keeping gene, ␤-actin.
In vivo experiments
Recombinant murine IL-1␤, recombinant murine IFN-␥, or combinations of both (PeproTech) were administered i.p. (250 l) to groups of 5-9 wild-type BALB/c mice (25-27 g; Harlan U.K., Bicester, U.K.) as described previously described (28) . Control animal received 250 l of PBS. At periods between 30 min and 24 h animals, were sacrificed and the peritoneum lavaged with 2 ml of PBS containing 5 IU/ml heparin (CP Pharmaceuticals, Wrexham, U.K.). Total leukocyte counts were assessed by Coulter counting (Coulter ZM, High Wycombe, U.K.) and corrected for specific cell phenotypes by differential leukocyte counts on Neat-stained (Guest Medical) cytospin preparations. Lavage fluid was rendered cell-free by centrifugation (150 ϫ g, 10 min) and stored at Ϫ70°C before chemokine assay.
Statistical analysis
Data are presented as mean Ϯ SEM. The values stated in the results section for fold increases or percentage inhibitions of chemokine production are the mean of the fold increases or percentage inhibitions observed in each individual experiment. Numbers (n) for all data refer to the number of different donors tested. Statistical analyses were performed by the Wilcoxon matched-pairs signed ranks test or unpaired Students-t test as appropriate (Statview SE; Abacus Concepts, Berkeley, CA) with a p value of less than 0.05 considered significant.
Results

IFN-␥ regulation of MCP-1, RANTES, and IL-8 protein production
IFN-␥ stimulation of HPMC resulted in a dose-dependent increase in MCP-1 production, and 100 U/ml IFN-␥ had similar efficacy for MCP-1 production as 1000 pg/ml TNF-␣ (Fig. 1A) . Stimulation with a combination of IFN-␥ and IL-1␤ (100 pg/ml) or TNF-␣ (1000 pg/ml) resulted in significant ( p Ͻ 0.05) synergistic upregulation of MCP-1 production at a 100 U/ml dose of IFN-␥, where production was above the levels produced by any of the stimuli alone and significantly above the predicted additive value. Combination of 100 U/ml IFN-␥ with either IL-1␤ or TNF-␣ resulted in a mean fold increase in MCP-1 levels above the expected additive values of 1.8 Ϯ 0.3 (range of 1.1-to 3.0-fold; n ϭ 5) and 1.8 Ϯ 0.2 (range of 1.1-to 2.1-fold; n ϭ 5), respectively.
Analysis of RANTES production in the same cell supernatants showed IFN-␥ alone resulted in a minor, nonsignificant ( p Ͻ 0.05) induction of RANTES peptide production at 100 U/ml dose of IFN-␥ (Fig. 1B) . However, the combination of IFN-␥ with either IL-1␤ or TNF-␣ resulted in marked synergistic, dose-dependent up-regulation of RANTES production compared with the expected additive value. The potentiating effects of IFN-␥ were greater for the TNF-␣ response, where a mean fold increase of 84 Ϯ 35 (range of 21-to 202-fold; n ϭ 5) was observed above the expected additive values at a 100 U/ml dose of IFN-␥, compared with a fold increase of 8.9 Ϯ 1.8 (range of 5-to 16-fold, n ϭ 5) in the IL-1␤ response.
In marked contrast, IFN-␥ caused a significant ( p Ͻ 0.05) down-regulation of basal and IL-1␤-and TNF-␣-induced IL-8 production (Fig. 1C) . The inhibitory activity of 10 U/ml IFN-␥ on basal IL-8 production was 86 Ϯ 8.5% (range of 66 -100%; n ϭ 5), on IL-1␤-induced IL-8 was 31 Ϯ 8.0% (range of 15-54%; n ϭ 5), and on the TNF-␣ response was 35 Ϯ 10% (range of 8.1-64%; n ϭ 5). The inhibitory activity of IFN-␥ on basal and TNF-␣ induced-IL-8 was maximal at a 10 U/ml dose, whereas IFN-␥ at 10 or 100 U/ml caused similar down-regulation of IL-1␤-induced IL-8 production.
The regulatory activity of IFN-␥ on IL-1␤-or TNF-␣-stimulated chemokine production was dependent on the dose of IL-1␤ (or TNF-␣) used (Fig. 2) . The synergistic effect of combined stimulation with IFN-␥ (100 U/ml) and IL-1␤ (or TNF-␣) on MCP-1 production became significant ( p Ͻ 0.05) above the additive values, at doses of 100 pg/ml IL-1␤ ( Fig. 2A) or 1000 pg/ml TNF-␣ and above (data not shown). Maximal synergy was observed at 100 pg/ml IL-1␤ and 1000 pg/ml TNF-␣. For RANTES production by HPMC, the synergistic effects of IFN-␥ became significant ( p Ͻ 0.05) above the additive values at and above a 10 pg/ml dose of IL-1␤ (Fig. 2B) and 1000 pg/ml of TNF-␣. Maximal synergy was observed with 100 pg/ml IL-1␤ and 10,000 pg/ml TNF-␣ (data not shown).
The inhibitory effect of IFN-␥ on IL-8 production first became significant ( p Ͻ 0.05) at a 10 pg/ml dose of IL-1␤ and 100 pg/ml dose of TNF-␣. At these cytokine doses, maximum down-regulation of 96 Ϯ 2.9% (range of 85-100%; n ϭ 5) and 78 Ϯ 14% (range of 33-100%; n ϭ 5) respectively, were observed (Fig. 2, C  and D) . The regulatory effects of IFN-␥ on IL-8 production therefore were maximal at Ն 10-fold lower doses of IL-1␤ or TNF-␣ than MCP-1 or RANTES. The percentage of inhibition of cytokine-induced IL-8 production by IFN-␥ then decreased with increasing dose of IL-1␤ or TNF-␣. Interestingly, the regulatory effect of IFN-␥ on TNF-␣-induced IL-8 production was biphasic across the TNF-␣ dose range used, as IFN-␥ in combination with 10,000 pg/ml TNF-␣, the highest dose used, resulted in increased IL-8 generation compared with stimulation with a corresponding dose of TNF-␣ alone.
Time-dependent regulation of IL-1␤-induced chemokine expression and production by IFN-␥
PCR analysis was performed to determine whether the regulatory effects of IFN-␥ on IL-1␤-induced chemokine generation were observed at the level of gene expression. Stimulation with a combination of IFN-␥ (100 U/ml) and IL-1␤ (100 pg/ml) resulted in increased expression of IL-1␤-induced MCP-1 and RANTES mRNA levels, compared with either stimuli alone (Fig. 3) . The potentiating effect of IFN-␥ on IL-1␤-induced MCP-1 expression was observed by 1 h, was maximal by 6 h, and remained similarly up-regulated over the whole time course used (24 h). The combination of IFN-␥ and IL-1␤ induced a prolonged time course of RANTES mRNA expression compared with IL-1␤ alone, with upregulation first observed at 12 h and continuing to increase up to 24 h. In comparison, down-regulation of IL-1␤-induced IL-8 mRNA expression was observed in the presence of IFN-␥ (Fig.  3C) . The inhibitory effect of IFN-␥ was greatest after cytokine stimulation for 1 to 6 h; after 6 h, the inhibitory effect of IFN-␥ on IL-1␤ induced IL-8 mRNA levels decreased.
Protein time course studies support our PCR data and indicate that the potentiation of IL-1␤-induced MCP-1 or RANTES protein production by IFN-␥ was maximal after longer cytokine stimulation times (of 36 h or more for protein production). In contrast, the inhibition of IL-1␤-induced IL-8 production by IFN-␥ was maximal after a 24-hour stimulation, and decreased thereafter (Fig.  4A-C) .
Quantitation of the IFN-␥ regulation of chemokine mRNA expression
To quantitate the changes in chemokine mRNA abundance, we examined IFN-␥ (100 U/ml)-induced changes in basal and IL-1␤ (100 pg/ml)-and TNF-␣ (1000 pg/ml)-induced chemokine mRNA expression by Northern analysis with appropriate cytokine stimulation times for each chemokine. After a 4-h cytokine stimulation of HPMC, IFN-␥ increased basal and IL-1␤-and TNF-␣-induced MCP-1 mRNA expression by a fold increase of 7.4 Ϯ 2.2, 1.7 Ϯ 0.5, and 4.0 Ϯ 1.0 (n ϭ 3), respectively (Fig. 5A) . Probing of the same blots for IL-8 showed basal IL-8 expression was inhibited by 72 Ϯ 28%, IL-1␤ induced IL-8 by 47 Ϯ 14%, and TNF-␣ induced IL-8 by 69 Ϯ 10% (n ϭ 3; Fig. 5A ). Basal expression of RANTES mRNA transcripts examined after a 24-h stimulation period were undetectable, whereas stimulation with IFN-␥ alone caused a minor induction of RANTES mRNA expression (Fig. 5B) . The combination of IFN-␥ with IL-1␤ or TNF-␣ fold-increased RANTES expression by 12 Ϯ 2.4 and 28 Ϯ 9.5 (n ϭ 2), respectively, compared with IL-1␤ or TNF-␣ stimulation alone.
Effect of timing of IFN-␥ addition
The mRNA expression studies demonstrated that the regulatory effects of IFN-␥ on IL-1␤-or TNF-␣-induced chemokine production were observed at the level of gene expression, indicating that IFN-␥ modulates the IL-1␤ and TNF-␣ signal transduction pathways at a pretranslational level. To begin to investigate the mechanisms involved in the IFN-␥ regulation of CC and CXC chemokine synthesis, we examined the effect of timing of IFN-␥ addition on its ability to regulate IL-1␤-induced RANTES and IL-8 production. Fig. 6A shows the potentiating effect of IFN-␥ on IL-1␤-induced RANTES production was significantly ( p Ͻ 0.05) greater when cells were pretreated (for 5 h) with IFN-␥, compared with the simultaneous addition of both cytokines for 24 h. Both of these conditions resulted in significantly ( p Ͻ 0.05) increased RANTES production compared with pretreatment of HPMC with IL-1␤ for 5 h before IFN-␥ addition. These findings indicated that IFN-␥ might act to prime the cells for subsequent induction of RANTES by IL-1␤. Therefore, we examined the effect of sequential addition of IL-1␤ and IFN-␥ on RANTES production (Table I) . HPMC were incubated in the presence or absence of IL-1␤ or IFN-␥ for 24 h before washing and culturing the cells for a further 24 h in the absence or presence of the cytokines. Incubation with IFN-␥ for the first 24 h and IL-1␤ for the second 24 h resulted in a potentiation of RANTES production. In contrast, IFN-␥ had no effect when added after IL-1␤. Similar results were obtained when studying the combination of IFN-␥ and TNF-␣ (data not shown). These results indicate IFN-␥ can prime HPMC for the stimulatory activity of IL-1␤ (or TNF-␣) on RANTES generation. No significant difference in the down-regulation of IL-1␤-induced IL-8 production by IFN-␥ was observed in any of the three initial stimulation conditions used (Fig. 6B) , indicating the timing of IFN-␥ addition did not effect its potential to inhibit IL-8 generation.
Regulation of PMN transmigration across HPMC monolayers
To determine whether the regulatory effect of IFN-␥ on HPMC IL-8 production translated into a functional effect of IFN-␥ on transmesothelial PMN migration, we used an in vitro transmigration system. HPMC were stimulated apically with doses of IL-1␤ (10 pg/ml) or TNF-␣ (100 pg/ml) which, in combination with IFN-␥ (10 U/ml) were known to result in maximal inhibition of IL-8 production. Fig. 7 shows that in the presence of IFN-␥-, IL-1␤ (188, 772 Ϯ 165, 600 PMN; n ϭ 3)-, or TNF-␣ (52, 705 Ϯ 26, 834 PMN; n ϭ 3)-stimulated PMN transmigration were reduced by 56 Ϯ 11% and 52 Ϯ 14% compared with control (unstimulated) levels (n ϭ 3; p Ͻ 0.05). No significant inhibition of PMN transmigration by IFN-␥ was observed when higher doses of IL-1␤ (100 pg/ml) or TNF-␣ (1000 pg/ml) were used (data not shown).
Regulation of PMN recruitment in vivo
To determine whether our in vitro observations on the control of PMN recruitment were operative in the peritoneal cavity in vivo, recombinant murine IL-1␤ and IFN-␥ were injected, either singly or in combinations, i.p. in wild-type BALB/c mice. Initial time course experiments identified that PMN recruitment peaked at 3 h after injection in response to IL-1␤ or staphylococcal supernatanttreated mice (Ref. 28 ; Fig. 8A ). This increase in PMN numbers was preceded by a rapid and time-dependent increase in KC (the murine counterpart of human GRO␣), peaking 1 h after injection (Fig.  8B) . In subsequent experiments at 1 and 3 h, injection of IL-1␤ induced a dose-dependent and significant increase in both KC and PMN levels compared with PBS-injected control animals (Fig. 8,  C and D) . In subsequent experiments at these time points, combinations of IL-1␤ (a dose of 100 ng/mouse was selected based on the dose response experiments) and increasing IFN-␥ concentrations were injected simultaneously into wild type mice. In these experiments, i.p. PMN numbers at 3 h increased from 1.66 Ϯ 1.04 (ϫ10 5 ) in PBS injected animals to 7.61 Ϯ 2.12 (ϫ10 5 ) in animals injected with 100 ng/mouse of IL-1␤ (mean Ϯ SEM; n ϭ 5; p Ͻ 0.05; Fig. 8E ). When IFN-␥ (0.05-50 ng) was combined with IL-1␤ (100 ng/ml) there was a dose-dependent decrease in PMN numbers in the peritoneal lavage fluid. At doses between 0.5 and 50 ng/mouse, PMN numbers were significantly reduced compared with IL-1␤ treatment alone. At these higher IFN-␥ doses, PMN numbers were reduced by 60.58, 68.47, and 80.29% for IFN-␥ doses of 0.5, 5.0, and 50 ng/mouse, respectively (n ϭ 5-7; p Ͻ 0.05 for all; Fig. 8E ). Injection of IL-1␤ (100 ng/mouse) into wildtype mice resulted in a significant increase in i.p. KC concentrations at 1 h (Fig. 8F) . Coinjection of IL-1␤ (100 ng/mouse) with increasing concentrations of IFN-␥ (0.05-50 ng/mouse), resulted in a dose-dependent decrease in i.p. KC levels (Fig. 8F) . At the highest doses of IFN-␥ used, these represented 65.9 and 92.5% reductions of the levels induced by IL-1␤ alone (n ϭ 6 -8 animals/ group; p Ͻ 0.05 for both) (Fig. 8F) . IFN-␥ (50 ng/mouse) alone did not induce significant PMN influx or elevation of KC levels.
Discussion
The ability of chemokines to recruit specific leukocyte subpopulation is thought to play a key role in mediating the distinct phases of inflammatory cell infiltration during the progression of an immune response (29) . However, the mechanisms involved in 'switching' the leukocyte infiltrate during bacterial infection from a predominantly PMN to a MNC phenotype remain to be fully defined (13) . The complex, multistep process of leukocyte extravasation indicates that this process may be regulated at several levels, including regulation of cell-chemokine production, chemokine receptor expression, and/or cell surface adhesion molecule expression (29, 30) . At the level of chemokine production, the potential of different chemokines to be induced (or repressed) with differing kinetics may be one of the mechanism involved in controlling the magnitude, time-dependency, and phenotype of specific leukocyte subsets recruited to sites of inflammation (28, (31) (32) (33) . The ability of local cytokine networks to differentially modulate chemokines of different leukocyte specificity also may play a role (34, 35) . Recent studies have highlighted the importance of IFN-␥, a Th1-type cytokine, in mononuclear-specific chemokine induction (33, 36) . In contrast, IFN-␥ has been reported to possess inhibitory activity for IL-8 generation in some, but not in all cell types examined (16, 37) .
In the present study, we examined the potential of IFN-␥ to regulate mononuclear and neutrophil-specific chemokine production and control the transcellular migration of leukocytes across HPMC monolayers in vitro and into the peritoneal cavity in vivo. We have examined the regulatory effects of IFN-␥ on constitutive as well as proinflammatory cytokine (IL-1␤ and TNF-␣)-induced HPMC-chemokine production with doses of cytokines known to be present in the peritoneal cavity during bacterial peritonitis (14, 15) . Our in vitro culture studies show that IFN-␥ alone was an efficient stimulus for MCP-1 production, and the combination of IFN-␥ with IL-1␤ (or TNF-␣) resulted in significant synergistic up-regulation of MCP-1 synthesis. In contrast, stimulation of HPMC with combinations of IFN-␥ and IL-1␤ (or TNF-␣) was required for significant induction of RANTES gene expression and protein production. This requirement for IFN-␥, in combination with IL-1␤ or TNF-␣, for significant RANTES generation, has been documented previously (17, 35) , and synergistic induction of IL-1␤-stimulated MCP-1 production by IFN-␥ (or IFN-␤) has been observed in human Hep-2 epithelial cells. However, in diploid fibroblasts, these two cytokines had an additive effect on MCP-1 production (38) .
In comparison to the two CC chemokines, IFN-␥ treatment resulted in both constitutive and IL-1␤-or TNF-␣-induced IL-8 gene expression and synthesis being significantly down-regulated. Previous reports on the ability of IFN-␥ to regulate IL-8 synthesis contrast in their findings. Oliveira et al. (16) described an inhibitory effect of IFN-␥ (and IFN-␤) on IL-1␣-or TNF-␣-induced IL-8 expression and production in FS-4 fibroblasts. Similarly, IFN-␥-and IFN-␤-inhibited neutrophil-specific chemokine production (IL-8, ENA-78) in LPS or IL-1␤ stimulated monocytes (37) . In contrast, Yasumoto et al. (39) reported synergistic up-regulation of IL-8 production with the combination of IFN-␥ and TNF-␣ in a human gastric cancer cell line, and in HPMC, Visser et al. (8) described no effect of IFN-␥ on basal or IL-1␤-or TNF-␣-induced IL-8 production. Our findings that the potential of IFN-␥ to regulate IL-8 production was critically dependent on the dose of IL-1␤ or TNF-␣ used, with inhibition evident at lower doses but stimulation present at higher ones, may in part explain the observed differences in the published literature.
Initial investigations into the mechanisms involved in the IFN-␥ regulation of chemokine synthesis by IL-1␤-or TNF-␣-stimulated HPMC by PCR and Northern analysis demonstrated the regulatory effects were observed at the level of gene expression. This indicates the cross-talk between the signal transduction pathways used by these cytokines for MCP-1, RANTES, and IL-8 regulation occurred at the pretranslational level. Studies on the effect of timing of IFN-␥ addition in relation to IL-1␤ demonstrated that IFN-␥ could "prime" HPMC to the subsequent actions of IL-1␤ (and TNF-␣, data not shown) for RANTES induction. The ability of IFN-␥ to prime cells for the subsequent actions of TNF-␣ for RANTES production has been reported previously in human endothelial and airway smooth muscle cells (17, 35) . Priming effects may be mediated at the level of receptor expression, and the ability of IFN-␥ to up-regulate cell surface TNF-␣ receptors has been FIGURE 6. Effect of timing of IFN-␥ addition on chemokine production by IL-1␤-stimulated HPMC. HPMC were pretreated with IFN-␥ (10 -100 U/ml) for 5 h before IL-1␤ (100 pg/ml) addition, treated with both cytokines simultaneously for 24 h, or pretreated with IL-1␤ (100 pg/ml) for 5 h before IFN-␥ (10-100 U/ml) addition. Cells then were washed and cultured for a further 24 h in the presence or absence of IL-1␤ and/or IFN-␥. HPMC supernatants then were harvested and analyzed for extracellular RANTES (A) or IL-8 (B) production by ELISA. Results are the mean Ϯ SEM; n ϭ 5 (A and B) . ‫,ء‬ Statistically significant increase (p Ͻ 0.05) vs IFN-␥ control (0). ‫,ڊ‬ Significant difference (p Ͻ 0.05) compared with the levels induced by IFN-␥ addition 5 h before IL-1␤ (100 pg/ml) at the respective IFN-␥ dose. demonstrated in several human tumor cell lines (40 -42) . However, this was only observed in cells with low constitutive TNF receptor expression (40) . Although the potential of IFN-␥ to modulate IL-1␤ or TNF-␣ receptor expression in HPMC was not determined in the present study, HPMC have previously been shown to express relatively high levels (7 ϫ 10 3 /cell) of the ubiquitous type 1 receptor (43) . Therefore, the mechanism by which IFN-␥ potentiates TNF-␣-induced RANTES expression in HPMC may be independent of TNF receptor modulation. In contrast, IFN-␥ has been reported to down-regulate basal and cytokine-induced IL-1 receptor (type I and type II) mRNA expression in human monocytes (44) . Therefore, priming of HPMC by IFN-␥ for RANTES (and possibly MCP-1) production would appear to occur independently of IL-1 or TNF receptor modulation, although clearly this requires further investigation.
Table I. Effect of sequential addition of IL-1␤ and IFN-␥ on RANTES production
The synergy between IFN-␥ and TNF-␣ for RANTES production demonstrated in endothelial cells did not occur at the level of surface TNF-␣ receptor expression, but occurred further downstream at the level of transcriptional control (17) . Cooperation between the transcription factors NF-B and STAT-1 have been shown to mediate, in part, the synergy between TNF-␣ and IFN-␥ for Mig and RANTES gene expression (45) . IFN-␥ also has been shown to mediate negative regulatory effects on gene expression at the level of transcription and mRNA stability. The role of these mechanisms in controlling HPMC chemokine synthesis remains to be defined. The potential of IFN-␥ to prime HPMC for subsequent RANTES synthesis, but not IL-8 induction, together with the significant differences observed in the dose responses and time courses of these events, suggests that several distinct signaling mechanisms may be involved in the observed differential regulation.
Previous in vitro data has suggested that the amount of IL-8 and the creation of a basolateral to apical concentration gradient is the primary determinant in directing PMN transmigration across HPMC monolayers (46) . Investigation of the functionality of the IFN-␥ regulation of HPMC chemokine production in relation to PMN recruitment was achieved both in vitro and in vivo in the present study. With an in vitro transwell system we demonstrated that although both IL-1␤ and TNF-␣ induced increases in PMN transmigration across HPMC monolayers, this increase could be attenuated by the simultaneous addition of IFN-␥. IFN-␥ itself had no effect on PMN migration in this system. This ability to downregulate PMN migration correlated directly with the ability of IFN-␥ to inhibit proinflammatory cytokine-induced IL-8 synthesis (Ն80% inhibition of IL-8 observed when parallel cytokine doses were used). As observed for the IFN-␥ regulation of IL-8 production, the doses of IL-1␤ or TNF-␣ were critical in determining the degree of PMN transmigration. Little or no inhibition of stimulated PMN migration was observed when higher doses of IL-1␤ (100 pg/ml) or TNF-␣ (1000 pg/ml) were used (data not shown), conditions which resulted in only partial (31-35%) inhibition of IL-8 secretion. Therefore, down-regulation of HPMC IL-8 production appears to be a major mechanism involved in mediating this inhibitory action of IFN-␥ on cytokine induced PMN transmigration.
IFN-␥ also can regulate PMN migration by exerting effects at the level of HPMC adhesion molecule expression. Previous reports indicate IFN-␥ up-regulates ICAM-1 expression on many cell types, including mesothelium (4, 47, 48) . We have shown previously that ICAM-1 was required for both basal and IL-1␤-induced transmesothelial PMN migration (7) . Furthermore, Issekutz and Lopes (49) have shown IFN-␥ superinduced LPS-stimulated ICAM-1 expression on human endothelial cells, prolonged E-selectin expression, and sustained LPS-induced PMN transmigration across freshly washed endothelial cell monolayers. Interestingly, the reported potentiating effects of IFN-␥ on ICAM-1 expression do not appear to fit with our current model of a role for IFN-␥ in inhibiting PMN recruitment. However, previous data suggests that the direction of PMN (and mononuclear cell) migration across HPMC monolayers is primarily dependent on the creation of a chemotactic gradient and only secondarily on the up-regulation of adhesion molecule expression (7) .
IFN-␥ may also regulate PMN migration in vivo at the level of chemokine receptor expression, and IFN-␥ has been shown recently to have a complex array of effects on chemokine receptors expressed on PMN (50), monocytes (51), and T lymphocytes (52) . These may function to modulate leukocyte infiltration to sites of inflammation, as well as their subsequent emigration. In light of the varied effects of IFN-␥ on factors known to play a role in mediating PMN migration, it is important to emphasize that in this study, under the experimental conditions used (particularly the cytokine doses), the regulatory effects of IFN-␥ culminated in significant inhibition of IL-1␤-induced PMN migration both in vitro and in vivo. Our in vivo data demonstrating the ability of IFN-␥ to abolish IL-1␤-induced acute PMN recruitment supports the in FIGURE 7. Regulatory effect of IFN-␥ on PMN transmigration across cytokine-stimulated HPMC monolayers. HPMC cultured on the underside of 3-M porous tissue culture inserts were apically stimulated with IL-1␤ (10 pg/ml) or TNF-␣ (100 pg/ml), in the presence or absence of IFN-␥ (10 U/ml), for 24 h before the addition of 2 ϫ 10 6 PMN to the upper chamber. PMN collected in the lower chamber after a 1-h transmigration period at 37°C were quantitated by an myeloperoxidase assay. Results are the mean Ϯ SEM; n ϭ 3. ‫,ء‬ Significant decrease compared with IL-1␤-or TNF-␣-induced transmigration. vitro findings on the ability of IFN-␥ to control PMN migration across HPMC. These data provide evidence for this pathway being important in switching off PMN recruitment during peritoneal inflammation. The mechanism controlling this effect in vivo appears to be the specific down-regulation of murine KC synthesis by IFN-␥. These data parallel our observations in IL-6-deficient mice that suggests that modulation of PMN recruitment during murine peritonitis is dependent on the control of macrophage-inflammatory protein-2 and KC synthesis (the murine equivalents of IL-8 and GRO␣; Ref. 28). However, there was a large difference in magnitude of the observed effects on PMN migration between the in vitro and in vivo migration assays and the regulation of HPMC IL-8 synthesis and mRNA expression by IFN-␥. These data suggest that in the in vitro transmigration assay where only PMN and HPMC are present and in the in vivo situation (where many cell types reside) that other soluble inhibitory/antagonistic factors serve to facilitate the down-regulation of IL-8 expression by IFN-␥. In this respect, ongoing studies suggest that soluble IL-6R, present in the peritoneal cavity during inflammation, plays a central role in this process (28) . However, to date, it is not known whether IFN-␥ plays a role in the generation of soluble IL-6R production (53) .
Although mesothelial cell-derived chemokine secretion may be the primary source of i.p. chemotactic activity at the onset of infection, inflammatory leukocytes subsequently migrate into the peritoneum and become major cell populations (54) . These leukocytes will become a major source of chemokine secretion. The reported potential of IFN-␥ to modulate chemokine secretion by mononuclear cells and PMN, (37, 55, 56) in an analogous manner to HPMC suggests that IFN-␥ plays an important role in controlling leukocyte recruitment throughout the inflammatory response.
In conclusion, we have shown that IFN-␥ differentially regulates IL-1␤-or TNF-␣-induced mononuclear and neutrophil-specific chemokine production by HPMC, an effect that correlated with an inhibitory action of IFN-␥ on IL-1␤-induced transmesothelial PMN migration. Therefore, IFN-␥ may play a role in controlling PMN recruitment during the evolution of an immune response. The role of IFN-␥ in controlling the temporal influx of neutrophils is supported by recent observations in IFN-␥-and ␣/␤ T celldeficient mice that suggest that its absence results in their delayed removal, resulting in inadequate clearance of infecting organisms and subsequent tissue damage (57) . This observation is supported by data generated after targeted disruption of the murine STAT-1-and Jak-1 genes that have cast further light on the importance of this signaling pathway in IFN-␥-mediated responses (58 -60) . STAT-1 deficiency (resulting in complete nonresponsiveness to IFN-␣ or IFN-␥) is associated with increased susceptibility to bacterial and viral infection (59, 60) . In the context of the present study, these data confirm the central role of IFN-␥ in the hosts response to infection and suggest that similar experiments in STAT-1-deficient animals might identify the cellular mechanisms controlling immunity against invading pathogens.
Taken together, these data suggest that IFN-␥ plays a central role in controlling neutrophil influx and may be one mechanism that polarizes the immune response toward a Th1 phenotype and adequate resolution of infection.
